Definitive Healthcare (NASDAQ:DH) Earns Equal Weight Rating from Analysts at Stephens

Stephens initiated coverage on shares of Definitive Healthcare (NASDAQ:DH) in a research note issued to investors on Friday morning, Marketbeat reports. The firm issued an equal weight rating and a $5.00 target price on the stock.

DH has been the topic of several other research reports. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research report on Friday, November 8th. BTIG Research assumed coverage on shares of Definitive Healthcare in a report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price objective on the stock. One analyst has rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $5.72.

Definitive Healthcare Stock Up 1.0 %

Definitive Healthcare stock opened at $4.18 on Friday. The stock’s fifty day moving average is $4.41 and its two-hundred day moving average is $4.68. The stock has a market cap of $482.89 million, a PE ratio of -1.35, a P/E/G ratio of 3.29 and a beta of 1.40. Definitive Healthcare has a 1-year low of $3.19 and a 1-year high of $10.62. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49.

Insider Transactions at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the transaction, the insider now owns 433,830 shares in the company, valued at $2,039,001. The trade was a 9.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 14.84% of the company’s stock.

Institutional Trading of Definitive Healthcare

A number of hedge funds have recently added to or reduced their stakes in the stock. Massachusetts Financial Services Co. MA lifted its stake in shares of Definitive Healthcare by 36.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock worth $27,058,000 after acquiring an additional 1,626,813 shares during the period. Millennium Management LLC acquired a new stake in Definitive Healthcare in the second quarter valued at about $9,283,000. State Street Corp lifted its position in Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company’s stock valued at $6,257,000 after purchasing an additional 317,952 shares during the period. 272 Capital LP increased its position in Definitive Healthcare by 74.8% during the 3rd quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock worth $4,980,000 after purchasing an additional 476,766 shares during the period. Finally, Granite Investment Partners LLC raised its stake in shares of Definitive Healthcare by 22.5% during the 2nd quarter. Granite Investment Partners LLC now owns 884,872 shares of the company’s stock worth $4,831,000 after buying an additional 162,432 shares in the last quarter. 98.67% of the stock is owned by institutional investors and hedge funds.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.